Dal Lago Marco Sells Shares of Stevanato Group
Stevanato Group's CFO, Dal Lago Marco, offloaded 7,997 shares on June 12, 2026.
Key Points
- Dal Lago Marco, CFO of Stevanato Group, sold 7,997 shares on June 12, 2026, with no planned sale indication.
- Shares of NYSE:STVN traded near $18.39 on Friday, with a market cap of about $5.02 billion and a P/E ratio of 31.7.
- Analysts, including TD Cowen and Wolfe Research, have recently rated the stock with buy ratings and set price targets.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Dal Lago Marco, the Chief Financial Officer of Stevanato Group S.p.A., sold 7,997 shares of the company on June 12, 2026. This transaction was not part of a pre-arranged trading plan. Stevanato Group trades on the NYSE under the ticker STVN.
Insider Buying and Selling at Stevanato Group S.p.A.
On June 12, 2026, Dal Lago Marco, the CFO of Stevanato Group, sold 7,997 shares. This sale was not under a Rule 10b5-1 plan, which means it wasn't pre-scheduled. Other insiders, including Karen Flynn, William Federici, Madhavan Balachandran, and Donald Morel Jr., also sold shares on June 15, 2026, each offloading 1,493 shares at an average price of $17.09.
Other Institutional Activity in Stevanato Group
Institutional investors have been active in Stevanato Group as well. Conestoga Capital Advisors, LLC increased its holdings by 602,050 shares, ending with 8,491,751 shares valued at approximately $116.76 million. On the other hand, Neuberger Berman Group LLC reduced its position by 312,219 shares, holding 4,475,492 shares worth about $61.54 million. TimesSquare Capital Management, LLC also trimmed its stake by 10,605 shares, while T. Rowe Price Investment Management, Inc. cut its position by 698,724 shares, now holding 3,224,908 shares valued at $44.34 million. Bamco Inc /NY/ added 498,714 shares, increasing its stake to 2,500,438 shares worth around $34.38 million.
Stevanato Group S.p.A. Stock Down 12.6%
Shares of Stevanato Group (NYSE:STVN) traded near $18.39 on Friday. The company has a market capitalization of approximately $5.02 billion and a P/E ratio of 31.7. Its forward P/E is 21.9, and it has a beta of 0.776, indicating less volatility than the market. The stock's 52-week range is between $12.89 and $28.00, with a 50-day moving average of $17.39 and a 200-day moving average of $19.57. Stevanato Group maintains a current ratio of 1.63 and a quick ratio of 1.11, with a debt-to-equity ratio of 29.43.
$STVN stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
In its recent earnings report, Stevanato Group posted revenue of approximately $1.20 billion, reflecting a growth rate of 6.6%. The company achieved a net margin of 11.75% and a return on equity of 9.59%. Earnings per share stood at $0.58. The next earnings announcement is expected on May 7, 2026.
Dividend
Stevanato Group offers an annual dividend rate of $0.06, yielding 0.34%. The dividend payout ratio is 10.59%.
Analysts Set New Price Targets
On June 16, 2026, TD Cowen initiated coverage of Stevanato Group with a buy rating and a $25.00 price target. Wolfe Research assumed coverage with a buy rating and a $21.00 target on June 2, 2026. The consensus among analysts is a buy, with a mean price target of $24.45 based on 10 analyst opinions.
About Stevanato Group
Stevanato Group S.p.A., headquartered in Piombino Dese, Italy, is a leading provider of products and solutions for the biopharma and healthcare industries. Founded in 1949, the company designs and produces drug containment solutions like syringes and vials, drug delivery systems, and diagnostic solutions. It operates across several regions, including Europe, the Middle East, and North America, serving a variety of clients in the pharmaceutical and biotechnology sectors. The company employs over 6,000 people and is led by CEO Franco Stevanato.
Bottom Line
Dal Lago Marco's recent sale of shares in Stevanato Group highlights ongoing insider trading activity. Investors often track such moves for potential insights into company performance. Stevanato Group's stock remains a point of interest, with analysts maintaining favorable ratings and setting optimistic price targets. As always, remember that insider transactions and 13F filings reflect past actions and may not indicate current positions.
Get Stevanato Group S.p.A. alerts
New 13F filings, insider trades, and analyst moves on $STVN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.